GlaxoSmithKline and Merix settle extended dispute over advertising practices
CHICAGO According to court documents filed last month, Merix Pharmaceutical and GlaxoSmithKline have settled a three-year dispute over advertising and competition practices for an undisclosed amount. “In exchange for certain consideration, the settlement agreement calls for Merix to dismiss with prejudice its claims against GSK, with each side to bear its own costs, expenses and attorneys’ fees,” the court documents, filed Sept. 2, read.
Merix had filed suit in March 2005 charging that certain advertising claims made by GlaxoSmithKline in support of its cold sore remedies Abreva and Valtrex may be false and misleading, using unreliable test data to promulgate advertising claims in an intentional effort to deceive doctors and the public.
McNeil rebrands Advanced Imodium Multi-Symptom Relief
FOR WASHINGTON, Pa. McNeil Consumer Healthcare on Thursday rebranded its Imodium Advanced Imodium Multi-Symptom Relief to better position the brand as the fastest anti-diarrheal medicine that also relieves symptoms of gas, cramps, bloating and pressure.
Imodium Multi-Symptom Relief combines loperamide hydrochloride with simethicone for relief of diarrhea, as well as the gas, cramps, bloating and pressure that nearly 65 percent of diarrhea sufferers can also experience. Loperamide HCl works in the small and large intestines by slowing the increased motility and reducing the increased secretion of fluid and electrolytes that occur with diarrhea. Simethicone acts in the stomach and intestines by altering the surface tension of gas and mucus bubbles, enabling them to group together. This action accelerates the passage of gas through the intestine.
Acute diarrhea is the second most commonly reported illness in the United States after respiratory infections. Diarrhea affects people of all ages, with the average adult suffering four bouts of acute diarrhea per year, and 22 million people reporting experiencing diarrhea at least once a month. Acute diarrhea also affects the travel plans of up to 10 million travelers each year.
Common causes of acute diarrhea include many medications, food intolerance, excessive caffeine or alcohol consumption and premenstrual syndrome.
Nellson, Ganeden team to create probiotic nutrition bars
LOS ANGELES Nellson Nutraceutical and Ganeden Biotech on Thursday entered into a collaboration in the development of probiotic-enhanced nutrition bars and powdered products.
The collaboration agreement underscores the companies’ commitment to developing innovative probiotic fortified food and beverage products designed to improve quality of life and provide health and wellness benefits to consumers. Nellson’s technical expertise in the area of nutrition bars and powdered products coupled with Ganeden Biotech’s leadership in probiotic products and supplements will accelerate product development initiatives, the two companies stated.
Unlike many other popular probiotics strains, Ganeden Biotech’s patented probiotic strain, GanedenBC30, is easily able to survive harsh manufacturing conditions and is shelf-stable, making it an ideal probiotic for nutrition bars and powder products.
“Partnering with an industry leader such as Nellson will enable us to broaden the applications of GanedenBC30 into more functional foods, beverages and engineered nutraceuticals applications,” Andrew Lefkowitz, Ganeden Biotech president and chief executive officer said. “The experience, knowledge and high standard of quality that Nellson brings to the market further support our commitment to provide superior probiotic ingredients.”
“We look forward to a long-term collaborative relationship with Ganeden Biotech through which we can help advance functional food and beverage products and develop new applications for healthy functional ingredients, including probiotics,” Allan Lutz, president and chief executive officer of Nellson Nutraceutical said. “Ganeden Biotech’s leadership in probiotics, including food and beverage applications, will help us bring superior functional foods and beverages to consumers.”